Facilitating the Development of Advanced Therapies
The European Medicines Agency’s (EMA) Committee for Advanced Therapies (CAT) and the International Society for Cellular TherapyExternal link icon (ISCT) are organising a workshop to discuss how to facilitate the development of advanced therapies on 25 September 2015 in Seville, Spain.
Under the title Challenges and Opportunities for the Successful Development and Approval of Advanced Therapy Medicinal Products (ATMPs), the workshop will bring together academics, developers and regulators for an open discussion on the requirements for a successful development of advanced therapies. Participants will get practical advice on the European authorisation procedure for advanced therapies and the tools and support available to them.
Every year, EMA teams up with an international learned society to organise a workshop in one of the EU Member States. This is an opportunity for the Agency to reach out to academic researchers and small and medium-sized enterprises to explain the regulatory framework for these innovative medicines and the development support the Agency offers.
The workshop will give attendees the opportunity to interact directly with regulators in an open forum discussion and learn more about
• quality development, manufacturing issues and non-clinical testing of ATMPs
• specificities of clinical development of ATMPs
• approval mechanism and EMA support available to ATMP developers
• new EU clinical trial regulation.
The deadline for registration is 18 September 2015. For further information on the workshop and how to register, please see the ISCT Europe 2015 website.
Related News
-
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Novartis agrees for copies to be made of cancer drug to reach poorer countries
Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News New WHO health emergency guidelines expect full transparency from Big Pharma
The WHO are proposing a new set of pandemic guidelines to set out how future global health crises should be handled.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance